Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
About this trial
Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.
Eligibility criteria
Qualifiers
Patients with a diagnosis of IMID.
Patients of any age, including minors.
Patients treated with approved medications for the condition in question and/or phototherapy.
Patients who agree to sign informed consent.
Disqualifiers
Patients without a diagnosis of IMID.
Patients who do not consent to sign informed consent.
Trial design
Treatments tested in this trial
- Questionnaires
Treatment groups
2,000 Participants
are divided into 12 treatment groups12
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov